Notably, the I148M PNPLA3 variant has been identified as a major co-genetic determinant of NAFLD (Wang et al., 2011; Valenti and Dongiovanni, 2017). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.